Co-authored publications with mentees

PhD mentee

• Moving Spatially Resolved Multiplexed Protein Profiling toward Clinical Oncology.

  Cancer discovery · 2023

  IKIngo K. MellinghoffMPMaryam Pourmaleki

  PMID: 37009699·PMCID: PMC10070169·DOI·5 citations·Abstract

  With Maryam Pourmaleki · Tri-I Program in Computational Biology & Medicine (PhD) · Class of 2023

• Noninvasive Imaging of CD4+ T Cells in Humanized Mice.

  Molecular cancer therapeutics · 2022

  IKIngo K. MellinghoffVLVeronica L NagleMSMaya S GrahamASAndrea SchietingerJSJason S. Lewis

  PMID: 35131877·PMCID: PMC8983497·DOI·13 citations·Abstract

  With Veronica Nagle · Pharmacology (PhD) · Class of 2021

• Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma.

  Cancer immunology research · 2022

  IKIngo K. MellinghoffMPMaryam PourmalekiASAndrea Schietinger

  PMID: 35013003·PMCID: PMC8898286·DOI·9 citations·Abstract

  With Maryam Pourmaleki · Tri-I Program in Computational Biology & Medicine (PhD) · Class of 2023

• Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [⁶⁴Cu]Cu-NOTA-anti-CD8 PET.

  Clinical cancer research : an official journal of the American Association for Cancer Research · 2021

  IKIngo K. MellinghoffVLVeronica L NagleMSMaya S GrahamLFLuis F Parada+1 more →JSJason S. Lewis

  PMID: 33495310·PMCID: PMC8026513·DOI·45 citations·Abstract

  With Veronica Nagle · Pharmacology (PhD) · Class of 2021

• Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer/testis antigens NY-ESO-1 and MAGE-A.

  Oncotarget · 2019

  IKIngo K. MellinghoffMPMaryam Pourmaleki

  PMID: 31692889·PMCID: PMC6817453·DOI·20 citations·Abstract

  With Maryam Pourmaleki · Tri-I Program in Computational Biology & Medicine (PhD) · Class of 2023

• Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas.

  Clinical cancer research : an official journal of the American Association for Cancer Research · 2019

  IKIngo K. MellinghoffMPMaryam PourmalekiRJRobert J. YoungDMDavid M HymanBTBob T Li+9 more →

  PMID: 31263031·PMCID: PMC6753053·DOI·136 citations·Abstract

  With Maryam Pourmaleki · Tri-I Program in Computational Biology & Medicine (PhD) · Class of 2023

• Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid.

  Nature · 2019

  IKIngo K. MellinghoffMPMaryam PourmalekiWHWan-Ying HsiehCGChristian GrommesMMMark M Souweidane+6 more →

  PMID: 30675060·PMCID: PMC6457907·DOI·556 citations·Abstract

  With Maryam Pourmaleki · Tri-I Program in Computational Biology & Medicine (PhD) · Class of 2023

• Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid.

  Nature · 2019

  IKIngo K. MellinghoffWHWan-Ying HsiehMPMaryam PourmalekiCGChristian GrommesMMMark M Souweidane+6 more →

  PMID: 30675060·PMCID: PMC6457907·DOI·556 citations·Abstract

  With Wan-Ying Hsieh · Pharmacology (PhD) · Class of 2018

• EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer.

  Nature communications · 2017

  IKIngo K. MellinghoffMPMaryam PourmalekiCGChristian GrommesCMCraig M BielskiJBJohn Blenis

  PMID: 29229958·PMCID: PMC5725448·DOI·28 citations·Abstract

  With Maryam Pourmaleki · Tri-I Program in Computational Biology & Medicine (PhD) · Class of 2023

• Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth.

  Cancer discovery · 2015

  IKIngo K. MellinghoffMCMichael C KaufmannZCZhen CaoYCYuedan Chen+2 more →PCPing Chi

  PMID: 25572173·PMCID: PMC4355391·DOI·124 citations·Abstract

  With Michael Kaufmann · Pharmacology (PhD) · Class of 2016

• A kinase-independent function of AKT promotes cancer cell survival.

  eLife · 2014

  IKIngo K. MellinghoffWHWan-Ying HsiehNYNicolas Yannuzzi

  PMID: 25551293·PMCID: PMC4337624·DOI·75 citations·Abstract

  With Wan-Ying Hsieh · Pharmacology (PhD) · Class of 2018